Holen Sie sich die Stockscreener-App
1.17
10.38%
0.11
Schlusskurs vom Vortag:
$1.06
Offen:
$1.09
24-Stunden-Volumen:
161.61K
Relative Volume:
1.12
Marktkapitalisierung:
$47.20M
Einnahmen:
$63.15M
Nettoeinkommen (Verlust:
$-40.30M
KGV:
-0.7006
EPS:
-1.67
Netto-Cashflow:
$-44.47M
1W Leistung:
+17.08%
1M Leistung:
-22.52%
6M Leistung:
-15.83%
1J Leistung:
-59.52%
1-Tages-Spanne:
$1.05
$1.18
1-Wochen-Bereich:
$1.00
$1.25
52-Wochen-Spanne:
$0.8645
$3.20
Tela Bio Inc Stock (TELA) Company Profile
Firmenname
Tela Bio Inc
Sektor
Branche
Telefon
484-320-2930
Adresse
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Vergleichen Sie TELA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.17 | 42.76M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Eingeleitet | Lake Street | Buy |
| 2019-12-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-12-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Tela Bio Inc Aktie (TELA) Neueste Nachrichten
TELA Bio Posts Steady Growth as Strategic Shift Sparks New Commercial Momentum - MSN
Goodwin Advises TELA Bio On $13 Million Underwritten Registered Direct Offering And Credit Refinancing - Mondaq
How to track smart money flows in TELA Bio Inc.2025 AllTime Highs & Consistent Return Strategy Ideas - newser.com
What MACD signals say about TELA Bio Inc.July 2025 Setups & Weekly High Return Forecasts - newser.com
Measuring TELA Bio Inc.’s beta against major indicesPortfolio Value Summary & High Accuracy Trade Signal Alerts - newser.com
How hedge fund analytics apply to TELA Bio Inc. stockBuy Signal & Expert Approved Trade Ideas - newser.com
How buybacks impact TELA Bio Inc. stock valuePortfolio Update Summary & Stepwise Swing Trade Plans - newser.com
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
TELA Bio (NASDAQ: TELA) to webcast Piper Sandler conference presentation on Dec. 3 - Stock Titan
What dividend safety score for TELA Bio Inc. stockJuly 2025 Setups & Expert-Curated Trade Recommendations - newser.com
Canaccord Genuity Maintains TELA Bio (TELA) Buy Recommendation - Nasdaq
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - MarketScreener
Canaccord Genuity Lowers Price Target on TELA Bio (TELA) to $4.0 - GuruFocus
Major Investment Alert: EW Healthcare Partners Fund 2 Acquires Millions in TELA Bio Stock - TipRanks
Owner EW Healthcare Partners Fund 2 LP Buys 3,604,000 ($4M) Of Tela Bio Inc [TELA] - TradingView
[Form 4] TELA Bio, Inc. Insider Trading Activity - Stock Titan
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio (NASDAQ: TELA) grants 30,200 RSUs and 25,000 stock options as inducement awards - Stock Titan
Does TELA Bio Inc. show high probability of rebound2025 Support & Resistance & Free Safe Capital Growth Stock Tips - newser.com
TELA Bio Appoints William Plovanic to Board - MSN
TELA Bio Reports Revenue Growth and Strategic Moves - MSN
TELA Bio’s Earnings Call: Growth Amid Challenges - TipRanks
Can TELA Bio Inc. stock deliver surprise earnings beatOil Prices & Target Return Focused Stock Picks - newser.com
TELA Bio, Inc. (NASDAQ:TELA) Q3 2025 Earnings Call Transcript - Insider Monkey
TELA Bio Set to Unveil Innovations at Piper Sandler’s Premier Healthcare Conference! - MSN
Citizens Maintains TELA Bio (TELA) Market Outperform Recommendation - Nasdaq
TELA Bio Secures $70M Loan for Growth Initiatives - TipRanks
TELA Bio Welcomes Jim Hagen with Strategic Equity Grant - MSN
Piper Sandler lowers TELA Bio stock price target to $1.25 on soft Q3 results By Investing.com - Investing.com South Africa
Piper Sandler lowers TELA Bio stock price target to $1.25 on soft Q3 results - Investing.com Nigeria
TELA Bio, Inc. Enter into Credit Agreement and Guaranty with Perceptive Credit Holdings V, LP - MarketScreener
[8-K] TELA Bio, Inc. Reports Material Event | TELA SEC FilingForm 8-K - Stock Titan
Analyst Matt O'Brien Reiterates Neutral Rating for TELA Bio (TEL - GuruFocus
Citizens Maintains TELA Bio (TELA) Rating, Lowers Price Target | - GuruFocus
These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings - Benzinga
TELA Bio stock price target lowered to $5 at Citizens on lower ASP - Investing.com Nigeria
TELA Bio reports 9% revenue growth in Q3, revises 2025 guidance - Investing.com Australia
Positive Sentiment Still Eludes TELA Bio, Inc. (NASDAQ:TELA) Following 26% Share Price Slump - simplywall.st
TELA Bio Q3 2025 Earnings Call Transcript - MarketBeat
TELA Bio Reports Q3 Revenue Growth and New Credit Facility - The Globe and Mail
TELA Bio Inc (TELA) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions ... By GuruFocus - Investing.com Canada
TELA Bio Inc (TELA) Q3 2025 Earnings Call Highlights: Revenue Gr - GuruFocus
TELA Bio Inc (TELA) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions ... - Yahoo Finance
Finanzdaten der Tela Bio Inc-Aktie (TELA)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):